Medicine and Dentistry
Hereditary Angioedema
77%
Disease
45%
Angioedema
44%
Complement Component C1s Inhibitor
30%
Diagnosis
20%
Icatibant
20%
Ichthyosis
17%
Isoniazid
16%
Quality of Life
12%
ACE Inhibitor
12%
Subacute Cutaneous Lupus Erythematosus
12%
Palmoplantar Keratoderma
10%
Self-Administration
8%
Clinical Feature
8%
Skin Defect
7%
Adverse Event
7%
Congenital Malformation
7%
Genodermatosis
7%
Inflammatory Disorder
7%
Systematic Review
6%
Prevalence
6%
Dermatosis
6%
Clinician
6%
Dermatology
6%
Porphyria Cutanea Tarda
6%
Cohort Analysis
6%
Rare Disease
5%
Genetic Disorder
5%
Exanthem
5%
Awareness
5%
Malignant Neoplasm
5%
Prospective Cohort Study
5%
Ectodermal Dysplasia
5%
Autosomal Recessive Inheritance
5%
Pharmacology, Toxicology and Pharmaceutical Science
Angioneurotic Edema
100%
Disease
27%
Complement Component C1s Inhibitor
26%
Dipeptidyl Carboxypeptidase Inhibitor
22%
Icatibant
16%
Skin Lupus Erythematosus
10%
Ichthyosis
10%
Adverse Event
8%
Isoniazid
8%
Cohort Study
8%
Edema
7%
Angiotensin Receptor Antagonist
7%
Bradykinin
6%
Biochemistry, Genetics and Molecular Biology
Hereditary Angioedema
39%
Angioedema
16%
C1-Inhibitor
12%
Genetics
10%
Autosomal Dominant Inheritance
8%
Enzyme Inhibitor
7%
Angiotensin-Converting Enzyme
7%
Cohort Study
7%
Autosomal Recessive Inheritance
7%
Molecular Genetics
5%
Angiotensin Receptor
5%
Icatibant
5%
